Overview
At Innovative Gene Therapy Solutions, we're on a mission to revolutionize healthcare for patients suffering from rare genetic disorders through advanced gene therapy technology. Our platform has developed a unique therapeutic approach that modifies genes to effectively treat conditions that currently have no viable treatment options. In 2025, we made significant strides with our initial proof-of-concept studies, demonstrating promising results in laboratory settings. We have since established partnerships with leading research institutions and gained regulatory support for upcoming clinical trials. The journey so far has validated our scientific premise, and we are now poised to transition into human trials. To fully realize our vision, we are seeking $1,200,000 in funding to enhance our research capabilities, expand our laboratory facilities, and support our clinical trial initiatives. This investment will enable us to move forward with a three-phase clinical study, paving the way for valuable data to attract further investment and partnerships. The healthcare landscape is rapidly evolving, particularly in the biotech sector, where advancements in gene therapy are unlocking new tr…
Use of funds
The $1,200,000 investment will be allocated as follows:
- Research and Development: $700,000 for clinical trial preparations and necessary laboratory enhancements.
- Regulatory Compliance: $200,000 for securing necessary approvals and certifications.
- Operational Costs: $200,000 for staffing and administrative expenses to facilitate rapid expansion.
- Marketing and Partnerships: $100,000 to establish strategic collaborations and brand awareness in the biotech community.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.